Literature DB >> 22489325

Perspectives on personalized cancer care.

Garrett M Dancika, Dan Theodorescu.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22489325      PMCID： PMC5373832          DOI： 10.1016/j.urolonc.2011.01.004

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  45 in total

1.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

Review 2.  Tumor-host interactions: a far-reaching relationship.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

3.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Authors:  Charles L Vogel; Melody A Cobleigh; Debu Tripathy; John C Gutheil; Lyndsay N Harris; Louis Fehrenbacher; Dennis J Slamon; Maureen Murphy; William F Novotny; Michael Burchmore; Steven Shak; Stanford J Stewart; Michael Press
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 4.  Epigenetics in cancer: implications for early detection and prevention.

Authors:  Mukesh Verma; Sudhir Srivastava
Journal:  Lancet Oncol       Date:  2002-12       Impact factor: 41.316

Review 5.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

6.  Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Authors:  Karla Kerlikowske; Annette M Molinaro; Mona L Gauthier; Hal K Berman; Fred Waldman; James Bennington; Henry Sanchez; Cynthia Jimenez; Kim Stewart; Karen Chew; Britt-Marie Ljung; Thea D Tlsty
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

Review 7.  The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer.

Authors:  Steven C Smith; Alexander S Baras; Jae K Lee; Dan Theodorescu
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

9.  Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force.

Authors:  Stacey L Sheridan; Russell P Harris; Steven H Woolf
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

Review 10.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.